U.S. Markets close in 3 hrs 8 mins
  • S&P 500

    3,628.08
    -7.33 (-0.20%)
     
  • Dow 30

    29,877.87
    -168.37 (-0.56%)
     
  • Nasdaq

    12,073.14
    +36.36 (+0.30%)
     
  • Russell 2000

    1,843.53
    -10.01 (-0.54%)
     
  • Crude Oil

    45.75
    +0.84 (+1.87%)
     
  • Gold

    1,807.90
    +3.30 (+0.18%)
     
  • Silver

    23.42
    +0.12 (+0.52%)
     
  • EUR/USD

    1.1922
    +0.0026 (+0.2146%)
     
  • 10-Yr Bond

    0.8650
    -0.0170 (-1.93%)
     
  • Vix

    21.78
    +0.14 (+0.65%)
     
  • GBP/USD

    1.3380
    +0.0022 (+0.1632%)
     
  • USD/JPY

    104.3300
    -0.1500 (-0.1436%)
     
  • BTC-USD

    18,947.84
    -318.80 (-1.65%)
     
  • CMC Crypto 200

    376.20
    +5.68 (+1.53%)
     
  • FTSE 100

    6,391.09
    -41.08 (-0.64%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

Tiziana Enters Human Trials for Covid-19 Treatment

Nov.02 -- Tiziana Life Sciences PLC is launching a clinical trial in Brazil involving humans where they will be treated with a nasally administered Foralumab, a monoclonal antibody. Gabriele Cerrone, the chief executive officer, speaks on "Bloomberg Markets."